Related Experiment Video
Updated: Feb 22, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.5K
Pancreatic neuroendocrine tumors. Prognostic factors
Javier A Cienfuegos1, Fernando Rotellar2, Miguel Ruiz-Canela3
1Cirugía/ Apoyo Investigación, Clínica Universidad de Navarra, España.
Revista Espanola De Enfermedades Digestivas
|September 21, 2017
Abstract:
We thank Modesto Varas et al. for their opportune comments with regard to the oncologic outcomes of our series of patients undergoing surgery for pancreatic neuroendocrine tumors (PNET). We agree with Varas et al. in relation to the increase in non-functional tumors (73%) and the incidental form of presentation (44%). These figures are in line with those presented in most series.
